2-26183002-C-G

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001168241.2(GAREM2):​c.289C>G​(p.Arg97Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000843 in 1,551,558 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00074 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00085 ( 2 hom. )

Consequence

GAREM2
NM_001168241.2 missense

Scores

2
8
8

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.713

Publications

3 publications found
Variant links:
Genes affected
GAREM2 (HGNC:27172): (GRB2 associated regulator of MAPK1 subtype 2)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.014363438).
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GAREM2NM_001168241.2 linkc.289C>G p.Arg97Gly missense_variant Exon 3 of 6 ENST00000401533.7 NP_001161713.1 Q75VX8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GAREM2ENST00000401533.7 linkc.289C>G p.Arg97Gly missense_variant Exon 3 of 6 1 NM_001168241.2 ENSP00000384593.1 Q75VX8-1
GAREM2ENST00000407684.1 linkc.58C>G p.Arg20Gly missense_variant Exon 2 of 6 2 ENSP00000384581.1 Q75VX8-3

Frequencies

GnomAD3 genomes
AF:
0.000742
AC:
113
AN:
152194
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00105
Gnomad ASJ
AF:
0.00519
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000970
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000829
AC:
126
AN:
151960
AF XY:
0.000842
show subpopulations
Gnomad AFR exome
AF:
0.000126
Gnomad AMR exome
AF:
0.000729
Gnomad ASJ exome
AF:
0.00531
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000871
Gnomad OTH exome
AF:
0.00277
GnomAD4 exome
AF:
0.000854
AC:
1195
AN:
1399364
Hom.:
2
Cov.:
31
AF XY:
0.000853
AC XY:
589
AN XY:
690194
show subpopulations
African (AFR)
AF:
0.000475
AC:
15
AN:
31598
American (AMR)
AF:
0.000644
AC:
23
AN:
35704
Ashkenazi Jewish (ASJ)
AF:
0.00647
AC:
163
AN:
25182
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35738
South Asian (SAS)
AF:
0.0000631
AC:
5
AN:
79236
European-Finnish (FIN)
AF:
0.000101
AC:
5
AN:
49270
Middle Eastern (MID)
AF:
0.00509
AC:
29
AN:
5698
European-Non Finnish (NFE)
AF:
0.000810
AC:
874
AN:
1078942
Other (OTH)
AF:
0.00140
AC:
81
AN:
57996
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
69
138
206
275
344
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000742
AC:
113
AN:
152194
Hom.:
0
Cov.:
33
AF XY:
0.000673
AC XY:
50
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.000169
AC:
7
AN:
41444
American (AMR)
AF:
0.00105
AC:
16
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00519
AC:
18
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5198
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000970
AC:
66
AN:
68032
Other (OTH)
AF:
0.00143
AC:
3
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
7
14
21
28
35
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00120
Hom.:
0
Bravo
AF:
0.000684
ExAC
AF:
0.000461
AC:
12

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Nov 09, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.289C>G (p.R97G) alteration is located in exon 3 (coding exon 3) of the GAREM2 gene. This alteration results from a C to G substitution at nucleotide position 289, causing the arginine (R) at amino acid position 97 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.67
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.31
CADD
Uncertain
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.048
T;.
Eigen
Uncertain
0.50
Eigen_PC
Uncertain
0.48
FATHMM_MKL
Uncertain
0.77
D
LIST_S2
Uncertain
0.96
D;D
M_CAP
Benign
0.028
D
MetaRNN
Benign
0.014
T;T
MetaSVM
Benign
-0.86
T
PhyloP100
0.71
PrimateAI
Uncertain
0.58
T
PROVEAN
Pathogenic
-4.7
D;D
REVEL
Benign
0.12
Sift
Uncertain
0.0030
D;D
Sift4G
Uncertain
0.0050
D;D
Polyphen
1.0
D;.
Vest4
0.41
MVP
0.56
ClinPred
0.083
T
GERP RS
5.5
Varity_R
0.67
gMVP
0.66
Mutation Taster
=45/55
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199966839; hg19: chr2-26405871; API